Allogene Therapeutics (NasdaqGS:ALLO) Q3 2026 Earnings call November 05, 2026 05:00 PM ET Company Participants Christine Cassiano - Chief Corporate Affairs and Brand Strategy Officer Zachary Roberts - President and CEO Geoff Parker - CFO Conference Call Participants Tyler Van Buren - Analyst Michael Yee - Analyst Roger Song - Analyst None - Analyst Samantha Semenkow - Analyst Matthew Phipps - Analyst Jack Allen - Analyst John Newman - Analyst None - Analyst Brian Cheng - Analyst Robert Burns - Analyst None ...